Maccabi Tel Aviv Wins Derby Amidst Two Player Injuries
Translated & summarized from Sport5 by baba
Maccabi Tel Aviv defeated Hapoel Tel Aviv 80-73 in a derby game on Thursday, marking their second win in three days. The victory was overshadowed by injuries to players Yam Madar, who broke his nose, and Oshey Brissett, who suffered a hip injury. Madar received medical treatment for his nose and his availability for Saturday's game is uncertain, while Brissett is not expected to play.
The story in 5 lines · by baba
- Maccabi Tel Aviv beat Hapoel Tel Aviv 80-73 in a derby on Thursday.
- Yam Madar suffered a broken nose and received medical treatment.
- Oshey Brissett sustained a hip injury after a hard fall.
- Madar's availability for Saturday's game against Hapoel Jerusalem is uncertain.
- Brissett is not expected to participate in the next game.
Maccabi Tel Aviv secured their second derby victory over Hapoel Tel Aviv within three days, winning 80-73 on Thursday. However, the win was marred by significant injuries to two key players, Yam Madar and Oshey Brissett. Madar confirmed after the game that he suffered a broken nose, with the team noting his strong desire to return to the court. On Friday, the club reported that Madar underwent a medical procedure to reset the bone. He will not practice Friday due to high sensitivity, and a decision on his participation in Saturday's game against Hapoel Jerusalem will be made closer to tip-off.
Brissett sustained a hip injury after an awkward landing following a block by the player, which sent him forcefully to the floor. He received treatment in the locker room for pain and did not return to the game. Brissett, who contributed 4 points and 5 rebounds with a strong defensive presence, is not expected to play in the upcoming game.
The same event, reported separately by each outlet. Open a few to compare what different newsrooms emphasize — and what they leave out.
Left 1Centre 2Other 1
Not the same event — other stories that share this one’s people, places, or theme: background, reactions, and follow-ups.
